Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of
Markets Covered in This Report 14
3.1 In Vitro Diagnostics 14
3.2
Clinical Chemistry Test Reagents 14
3.2.1 Laboratory Reagents 14
3.2.2
Clinical Chemistry Calibrators and Controls 14
3.2.3 Clinical Chemistry
Rapid Tests 14
3.3 Immunochemistry Test Reagents 14
3.3.1 Disease
Specific Markers 14
3.3.1.1 Tumor Markers 14
3.3.1.2 Cardiac Markers
15
3.3.2 Disease Specific Test Reagents 15
3.3.2.1 Auto-Immune Disease
15
3.3.2.2 Rheumatoid Disease 15
3.3.2.3 Anemia/ Vitamins 15
3.3.2.4 Allergy 15
3.3.3 Drug Related Testing Reagents 15
3.3.3.1
Therapeutic Drugs 15
3.3.3.2 Drug of Abuse and Toxicology 16
3.3.4
Hormone Related Testing Reagents 16
3.3.4.1 Specific Proteins 16
3.3.4.2 Fertility and Pregnancy 16
3.3.4.3 Individual/Specified hormones
16
3.3.4.4 Specific Organ Function 16
3.3.5 Immunochemistry
Calibrators and Controls 16
3.3.6 Immunochemistry Rapid Tests 16
3.4
Blood Test Reagents 17
3.4.1 Hematology Test Reagents 17
3.4.1.1
Hematology 17
3.4.1.2 Immunohaematology 17
3.4.1.3 Hematology
Calibrators and Controls 17
3.4.1.4 Immunohaematology Controls 17
3.4.2 Hemostasis Test Reagents 17
3.4.2.1 Hemostasis 17
3.4.2.2
Hemostasis Calibrators and Controls 17
3.4.2.3 Hemostasis Rapid Tests
18
3.4.3 Tissue Typing Reagents 18
3.4.4 Monoclonal Antibodies 18
3.4.5 Cytokines and Immunomodulators 18
3.4.6 Histology and Cytology
Reagents 18
3.5 Microbiology Test Reagents 18
3.5.1 Bacteriology Test
Reagents 18
3.5.1.1 Bacteriology Culture 18
3.5.1.2 Blood Culture
18
3.5.1.3 Bacteriology Identification and Susceptibility 18
3.5.2
Microbiology Calibrators and Controls 19
3.5.3 Microbiology Rapid Tests
19
3.6 Infectious Immunology Test Reagents 19
3.6.1 Bacteriology
19
3.6.2 Virology 19
3.6.2.1 Hepatitis Viruses 19
3.6.2.2
Retroviruses 19
3.6.3 Parasitology 19
3.6.4 Infectious Immunology
Calibrators and Controls 19
3.6.5 Infectious Immunology Rapid Tests 20
3.7 Genetic Test Reagents 20
3.8 Self Testing 20
3.9 Instruments
20
4 Healthcare Sector Review 21
4.1 Healthcare Sector Review 21
4.2 Healthcare Expenditure 21
4.3 Healthcare Infrastructure 23
4.3.1
Healthcare Personnel Data 24
4.3.2 Healthcare Facilities Data 25
4.4
Healthcare Policy 26
5 Regulation System 27
5.1 Medical Equipment
Approval Process 27
5.1.1 Classification 28
5.1.2 Conformity
Assessment Process 36
5.1.2.1 Class I devices 37
5.1.2.2 Class IIa
devices 38
5.1.2.3 Class IIb devices 39
5.1.2.4 Class III devices
40
5.1.3 Registration Fee 40
5.1.4 Registration Period 40
5.2 Post
Market Surveillance (PMS) 41
6 Pricing and Reimbursement 42
6.1
Pricing and Reimbursement Policies 42
7 Distribution Structure 43
7.1
France Medical Equipment Distribution Structure 43
8 In Vitro Diagnostics
In France 44
8.1 In Vitro Diagnostics, France, Overall Revenue ($ mn),
2000-2015 44
8.2 In Vitro Diagnostics, France, Company Share (2006-2007)
50
9 Blood Test Reagents In France 51
9.1 Blood Test Reagents Overall
Revenue (2000-2015) 51
9.1.1 Haematology Test Reagents Revenue (2000-2015)
55
9.1.2 Hemostasis Test Reagents Revenue (2000-2015) 57
9.2 Blood
Test Reagents Distribution Share (2007-2008) 59
9.3 Blood Test Reagents,
France, Company Share (2006-2007) 60
10 Clinical Chemistry Test Reagents
In France 61
10.1 Clinical Chemistry Test Reagents Overall Revenue
(2000-2015) 61
10.2 Clinical Chemistry Test Reagents Distribution Share
(2007-2008) 63
10.3 Clinical Chemistry Test Reagents, France, Company
Share (2006-2007) 64
11 Genetic Test Reagents In France 65
11.1
Genetic Test Reagents Overall Revenue (2000-2015) 65
11.2 Genetic Test
Reagents Distribution Share (2007-2008) 67
11.3 Genetic Test Reagents,
France, Company Share (2006-2007) 68
12 Immunochemistry Test Reagents In
France 69
12.1 Immunochemistry Test Reagents Overall Revenue (2000-2015)
69
12.1.1 Disease Specific Markers Revenue (2000-2015) 73
12.1.2
Disease Specific Test Reagents Revenue (2000-2015) 75
12.1.3 Drug Related
Testing Reagents Revenue (2000-2015) 77
12.1.4 Hormone Related Testing
Reagents Revenue (2000-2015) 79
12.2 Immunochemistry Test Reagents
Distribution Share (2007-2008) 81
12.3 Immunochemistry Test Reagents,
France, Company Share (2006-2007) 82
13 Infectious Immunology Test
Reagents In France 83
13.1 Infectious Immunology Test Reagents Overall
Revenue (2000-2015) 83
13.1.1 Virology Revenue (2000-2015) 87
13.2
Infectious Immunology Test Reagents Distribution Share (2007-2008) 89
13.3
Infectious Immunology Test Reagents, France, Company Share (2006-2007) 90
14 Instruments In France 91
14.1 Instruments Overall Revenue (2000-2015)
91
14.2 Instruments Distribution Share (2007-2008) 93
15 Microbiology
Test Reagents In France 94
15.1 Microbiology Test Reagents Overall Revenue
(2000-2015) 94
15.1.1 Bacteriology Test Reagents Revenue (2000-2015)
96
15.2 Microbiology Test Reagents Distribution Share (2007-2008) 98
15.3 Microbiology Test Reagents, France, Company Share (2006-2007) 99
16
Self Testing In France 100
16.1 Self Testing Overall Revenue (2000-2015)
100
16.2 Self Testing Distribution Share (2007-2008) 102
16.3 Self
Testing, France, Company Share (2006-2007) 103
17 Overview of Key
Companies in France In Vitro Diagnostics Market 104
17.1 F. Hoffmann-La
Roche Ltd. Company Profile 104
17.1.1 Company Overview 104
17.1.2
Value Chain Analysis 105
17.1.2.1 Manufacturing 105
17.1.2.2 Product
Development 105
17.2 Abbott Laboratories Company Profile 107
17.2.1
Company Overview 107
17.2.2 Value Chain Analysis 108
17.2.2.1
Manufacturing 108
17.2.2.2 Product Development 108
17.2.2.3 Sales and
Marketing 110
17.3 Dade Behring Holdings, Inc. Company Profile 111
17.3.1 Company Overview 111
17.4 bioMerieux S.A. Company Profile 112
17.4.1 Company Overview 112
17.4.2 Value Chain Analysis 113
17.4.2.1
Manufacturing 113
17.4.2.2 Product Development 114
17.4.2.3 Sales and
Marketing 115
17.5 Beckman Coulter, Inc. Company Profile 116
17.5.1
Company Overview 116
17.5.2 Value Chain Analysis 116
17.5.2.1
Manufacturing 117
17.5.2.2 Product Development 117
17.5.2.3 Sales and
Marketing 117
17.5.3 Beckman Coulter, Inc. Pipeline Products 118
17.5.3.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type 118
17.5.3.2 Beckman Coulter, Inc. Pipeline Products By Development Stage 119
17.5.3.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area 119
17.5.3.4 Beckman Coulter, Inc. Pipeline Products By News Summary 120
17.6
Siemens Healthcare Company Profile 121
17.6.1 Company Overview 121
17.6.2 Value Chain Analysis 122
17.6.2.1 Manufacturing 122
17.6.2.2
Product Development 122
17.6.2.3 Sales and Marketing 123
17.7 Argene
S.A. Company Profile 124
17.7.1 Company Overview 124
17.8 Diagnostica
Stago Company Profile 124
17.8.1 Company Overview 124
17.9 EUROMEDEX
Company Profile 125
17.9.1 Company Overview 125
18 Appendix 126
18.1 Global Markets Direct Research Methodology 126
18.2 Coverage 127
18.3 Secondary Research 127
18.4 Primary Research 128
18.5 Models
128
18.6 Forecasts 129
18.7 Expert Panel Validation 129
18.8
Currency Conversion 130
18.9 Contact Us 131
18.10 Disclaimer 131
1.1 List of Tables
Table 1: Number of Doctors by Specialty in France,
2003-2007 24
Table 2: Number of Hospital Wards by Specialty in France,
2003-2007 25
Table 3: In Vitro Diagnostics, France, Overall Revenue
($ mn), 2000-2015 44
Table 4: In Vitro Diagnostics, France, Cross-Category
Analysis, 2000-2015 45
Table 5: In Vitro Diagnostics, France, Overall
Revenue ($ mn), Historic, 2000-2008 47
Table 6: In Vitro Diagnostics,
France, Overall Revenue ($ mn), Forecast, 2008-2015 49
Table 7: In
Vitro Diagnostics, France, Company Share by Revenue ($ mn), 2006-2007 50
Table 8: Blood Test Reagents, France, Revenue ($ mn) by Segment,
Historic, 2000-2008 52
Table 9: Blood Test Reagents, France, Revenue
($ mn) by Segment, Forecast, 2008-2015 54
Table 10: Haematology Test
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 55
Table 11: Haematology Test Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 56
Table 12: Hemostasis Test
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 57
Table 13: Hemostasis Test Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 58
Table 14: Blood Test Reagents,
France, Distribution Share by Revenue ($mn), 2007-2008 59
Table 15:
Blood Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007 60
Table 16: Clinical Chemistry Test Reagents, France, Revenue ($ mn) by
Segment, Historic, 2000-2008 61
Table 17: Clinical Chemistry Test
Reagents, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 62
Table
18: Clinical Chemistry Test Reagents, France, Distribution Share by
Revenue ($mn), 2007-2008 63
Table 19: Clinical Chemistry Test
Reagents, France, Company Share by Revenue ($ mn), 2006-2007 64
Table 20:
Genetic Test Reagents, France, Revenue ($ mn), Historic, 2000-2008 65
Table 21: Genetic Test Reagents, France, Revenue ($ mn), Forecast,
2008-2015 66
Table 22: Genetic Test Reagents, France, Distribution
Share by Revenue ($mn), 2007-2008 67
Table 23: Genetic Test Reagents,
France, Company Share by Revenue ($ mn), 2006-2007 68
Table 24:
Immunochemistry Test Reagents, France, Revenue ($ mn) by Segment, Historic,
2000-2008 70
Table 25: Immunochemistry Test Reagents, France, Revenue
($ mn) by Segment, Forecast, 2008-2015 72
Table 26: Disease Specific
Markers, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 73
Table 27: Disease Specific Markers, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 74
Table 28: Disease Specific Test
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 75
Table 29: Disease Specific Test Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 76
Table 30: Drug Related Testing
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 77
Table 31: Drug Related Testing Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 78
Table 32: Hormone Related Testing
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 79
Table 33: Hormone Related Testing Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 80
Table 34: Immunochemistry Test
Reagents, France, Distribution Share by Revenue ($mn), 2007-2008 81
Table
35: Immunochemistry Test Reagents, France, Company Share by Revenue ($
mn), 2006-2007 82
Table 36: Infectious Immunology Test Reagents,
France, Revenue ($ mn) by Segment, Historic, 2000-2008 84
Table 37:
Infectious Immunology Test Reagents, France, Revenue ($ mn) by Segment,
Forecast, 2008-2015 86
Table 38: Virology, France, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 87
Table 39: Virology, France,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 88
Table 40:
Infectious Immunology Test Reagents, France, Distribution Share by Revenue
($mn), 2007-2008 89
Table 41: Infectious Immunology Test Reagents,
France, Company Share by Revenue ($ mn), 2006-2007 90
Table 42:
Instruments, France, Revenue ($ mn), Historic, 2000-2008 91
Table 43:
Instruments, France, Revenue ($ mn), Forecast, 2008-2015 92
Table 44:
Instruments, France, Distribution Share by Revenue ($mn), 2007-2008 93
Table 45: Microbiology Test Reagents, France, Revenue ($ mn) by Segment,
Historic, 2000-2008 94
Table 46: Microbiology Test Reagents, France,
Revenue ($ mn) by Segment, Forecast, 2008-2015 95
Table 47:
Bacteriology Test Reagents, France, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 96
Table 48: Bacteriology Test Reagents, France, Revenue ($
mn) by Sub-Segment, Forecast, 2008-2015 97
Table 49: Microbiology
Test Reagents, France, Distribution Share by Revenue ($mn), 2007-2008 98
Table 50: Microbiology Test Reagents, France, Company Share by Revenue ($
mn), 2006-2007 99
Table 51: Self Testing, France, Revenue ($ mn),
Historic, 2000-2008 100
Table 52: Self Testing, France, Revenue ($
mn), Forecast, 2008-2015 101
Table 53: Self Testing, France,
Distribution Share by Revenue ($mn), 2007-2008 102
Table 54: Self
Testing, France, Company Share by Revenue ($ mn), 2006-2007 103
Table 55:
Beckman Coulter, Inc. Pipeline Products by Equipment Type 118
Table
56: Beckman Coulter, Inc. Pipeline Products By Development Stage 119
Table 57: Beckman Coulter, Inc. Pipeline Products By Therapy Area 119
Table 58: Beckman Coulter, Inc. Pipeline Products By News Summary 120
Table 59: USD to Local Currency, Average Exchange Rate 2008 130
1.2
List of Figures
Figure 1: Total Healthcare Expenditure in France, 2000 -
2006 22
Figure 2: Flowchart for Classification of Non-invasive Devices in
France, 2007 29
Figure 3: Flowchart for Classification of Invasive Devices
in France, 2007 30
Figure 4: Flowchart for Classification of Invasive
Devices in France, 2007 31
Figure 5: Flowchart for Classification of
Invasive Devices in France, 2007 32
Figure 6: Flowchart for Classification
of Invasive Devices in France, 2007 33
Figure 7: Flowchart for
Classification of Active Devices in France, 2007 34
Figure 8: Flowchart
for Classification of Active Devices in France, 2007 35
Figure 9:
Flowchart for Classification of Devices except Non-invasive, Invasive and
Active Devices in France, 2007 36
Figure 10: Conformity Assessment of
Class-I Medical Devices in France, 2007 37
Figure 11: Conformity
Assessment of Class-IIa Medical Devices in France, 2007 38
Figure 12:
Conformity Assessment of Class-IIb Medical Devices in France, 2007 39
Figure 13: Conformity Assessment of Class-III Medical Devices in France, 2007
40
Figure 14: Medical Equipment Distribution Structure in France, 2007
43
Figure 15: In Vitro Diagnostics, France, Overall Revenue ($ mn),
2000-2015 44
Figure 16: In Vitro Diagnostics, France, Cross-Category
Analysis, 2000-2015 45
Figure 17: In Vitro Diagnostics, France,
Overall Revenue ($ mn), Historic, 2000-2008 46
Figure 18: In Vitro
Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015 48
Figure
19: In Vitro Diagnostics, France, Company Share (%), 2007 50
Figure
20: Blood Test Reagents, France, Revenue ($ mn) by Segment, Historic,
2000-2008 51
Figure 21: Blood Test Reagents, France, Revenue ($ mn)
by Segment, Forecast, 2008-2015 53
Figure 22: Haematology Test
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 55
Figure 23: Haematology Test Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 56
Figure 24: Hemostasis Test
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 57
Figure 25: Hemostasis Test Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 58
Figure 26: Blood Test Reagents,
France, Company Share (%), 2007 60
Figure 27: Clinical Chemistry Test
Reagents, France, Revenue ($ mn) by Segment, Historic, 2000-2008 61
Figure
28: Clinical Chemistry Test Reagents, France, Revenue ($ mn) by Segment,
Forecast, 2008-2015 62
Figure 29: Clinical Chemistry Test Reagents,
France, Company Share (%), 2007 64
Figure 30: Genetic Test Reagents,
France, Revenue ($ mn), Historic, 2000-2008 65
Figure 31: Genetic
Test Reagents, France, Revenue ($ mn), Forecast, 2008-2015 66
Figure 32:
Genetic Test Reagents, France, Company Share (%), 2007 68
Figure 33:
Immunochemistry Test Reagents, France, Revenue ($ mn) by Segment, Historic,
2000-2008 69
Figure 34: Immunochemistry Test Reagents, France,
Revenue ($ mn) by Segment, Forecast, 2008-2015 71
Figure 35: Disease
Specific Markers, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
73
Figure 36: Disease Specific Markers, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 74
Figure 37: Disease Specific Test
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 75
Figure 38: Disease Specific Test Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 76
Figure 39: Drug Related Testing
Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 77
Figure 40: Drug Related Testing Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 78
Figure 41: Hormone Related
Testing Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
79
Figure 42: Hormone Related Testing Reagents, France, Revenue ($
mn) by Sub-Segment, Forecast, 2008-2015 80
Figure 43: Immunochemistry
Test Reagents, France, Company Share (%), 2007 82
Figure 44:
Infectious Immunology Test Reagents, France, Revenue ($ mn) by Segment,
Historic, 2000-2008 83
Figure 45: Infectious Immunology Test
Reagents, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 85
Figure
46: Virology, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
87
Figure 47: Virology, France, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 88
Figure 48: Infectious Immunology Test
Reagents, France, Company Share (%), 2007 90
Figure 49: Instruments,
France, Revenue ($ mn), Historic, 2000-2008 91
Figure 50:
Instruments, France, Revenue ($ mn), Forecast, 2008-2015 92
Figure 51:
Microbiology Test Reagents, France, Revenue ($ mn) by Segment, Historic,
2000-2008 94
Figure 52: Microbiology Test Reagents, France, Revenue
($ mn) by Segment, Forecast, 2008-2015 95
Figure 53: Bacteriology
Test Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
96
Figure 54: Bacteriology Test Reagents, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 97
Figure 55: Microbiology Test
Reagents, France, Company Share (%), 2007 99
Figure 56: Self Testing,
France, Revenue ($ mn), Historic, 2000-2008 100
Figure 57: Self
Testing, France, Revenue ($ mn), Forecast, 2008-2015 101
Figure 58:
Self Testing, France, Company Share (%), 2007 103
Figure 59: F.
Hoffmann-La Roche Ltd Value Chain Analysis 105
Figure 60: Abbott
Laboratories Value Chain Analysis 108
Figure 61: Biomerieux Sa Value
Chain Analysis 113
Figure 62: Beckman Coulter, Inc. Value Chain
Analysis 116
Figure 63: Siemens Medical Solutions Value Chain
Analysis 122
Figure 64: Global Markets Direct Methodology 126
|
Related Report
|
View Cart
